Glen Eagle Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Glen Eagle Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 13, 2024	SELL	$213.32 - $257.83 $639 - $773	-3 Closed	0 $0
Q4 2022 Aug 13, 2024	BUY	$203.72 - $248.97 $611 - $746	3 New	3 $706,000
Q3 2021 Aug 13, 2024	SELL	$274.82 - $308.34 $5,221 - $5,858	-19 Closed	0 $0
Q4 2020 Aug 13, 2024	BUY	$186.91 - $214.42 $3,551 - $4,073	19 New	19 $3.87 Million
Q3 2019 Aug 13, 2024	BUY	$159.77 - $178.1 $3,035 - $3,383	19 New	19 $3.19 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.